Haleon (HLN) Return on Invested Capital (2023 - 2025)
Haleon's (HLN) quarterly Return on Invested Capital came in at 0.0% in Q4 2025, down 21.58% on a QoQ basis from 0.0% in Q4 2023.
Haleon (HLN) Return on Invested Capital (2023 - 2025) Analysis & Trends
Haleon (HLN) has 2 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2025.
- Quarterly Return on Invested Capital changed N/A year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.02%, up 1.0% from the prior year.
- Return on Invested Capital declined to 0.0% in Q4 2025, from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2023 to a low of 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | 0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| May 3, 2023 | 0.00% |